FIELD: medicine.
SUBSTANCE: present invention relates to immunology. Disclosed are fused proteins for inhibiting serine proteases, as well as use thereof.
EFFECT: present invention can find further application in therapy of various diseases, in particular emphysema, psoriasis and others.
18 cl, 17 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2012 |
|
RU2698655C2 |
FUSED SERPINE POLYPEPTIDES AND METHODS OF THEIR APPLICATION | 2015 |
|
RU2746550C2 |
POLYVALENT AND POLYSPECIFIC GITR-BINDING FUSED PROTEINS | 2016 |
|
RU2753439C2 |
FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE | 2019 |
|
RU2824402C2 |
METHODS OF TREATING TISSUE CALCIFICATION | 2015 |
|
RU2770698C2 |
HERPES VACCINE | 2019 |
|
RU2731073C1 |
FUSED POLYPEPTIDE WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2754466C2 |
EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
RECOMBINANT PROTEINS WITH CCN DOMAINS AND FUSION PROTEINS | 2020 |
|
RU2825102C2 |
POLYVALENT AND POLYSPECIFIC OX40-BINDING FUSED PROTEINS | 2017 |
|
RU2773052C2 |
Authors
Dates
2020-07-31—Published
2019-07-11—Filed